PepCalcs
    Back to Library

    Livagen

    Research Use OnlyPreclinical

    Livagen

    Description

    A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.

    Dose:2 mg
    Frequency:30 days in a row, 2-3x per year
    Administration Method: SQ
    CategoryBioregulator
    Half-LifeVery short (minutes); typical of Khavinson short peptides.

    Overview

    Livagen is a peptide bioregulator from the research of Dr. Vladimir Khavinson, designed to target the liver and immune system by influencing DNA and gene expression. Mechanistic and animal data are consistent, but clinical data are limited.

    Mechanism of Action

    Livagen is an ultra-short peptide that penetrates cell nuclei and interacts directly with DNA to restore youthful patterns of gene expression. It targets liver and immune-system tissues by influencing DNA structure and gene expression.

    Benefits

    • •Liver health
    • •Detoxification
    • •Tissue regeneration
    • •Metabolic support

    Reported Side Effects

    • •Limited human safety data
    • •Possible injection site reactions

    Safety Notes

    Research-use peptide bioregulator; no comprehensive clinical safety data in humans.

    Scientific References

    Related Bioregulator Peptides